STERIS plc (STE)
$
217.92
+1.70 (0.78%)
Key metrics
Financial statements
Free cash flow per share
9.3296
Market cap
21.4 Billion
Price to sales ratio
3.6699
Debt to equity
0.2865
Current ratio
2.4788
Income quality
1.7820
Average inventory
666 Million
ROE
0.1021
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
The operating income ratio is 0.16 indicating the company's operational profitability margin. The financial data pertains to the fiscal year 2025. The income before tax ratio is 0.15 reflecting the pre-tax margin. Additionally, the gross profit ratio is 0.44 reflecting the efficiency of the company's production and sales operations. STERIS plc reported a substantial revenue of $5,459,515,000.00 reflecting its strong market presence. The company provides a diverse range of infection prevention and procedural products and services worldwide, operating through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. Each segment plays a unique role, from offering cleaning chemistries and sterility assurance products in Healthcare to contract sterilization services through a network of approximately 50 facilities in Applied Sterilization Technologies. In Life Sciences, the company designs, manufactures, and sells consumable products such as formulated cleaning chemistries, while the Dental segment supplies hand and powered dental instruments along with infection control products. STERIS also offers equipment management, maintenance, and custom consulting services, catering to the needs of hospitals, healthcare providers, and pharmaceutical manufacturers. The stock is priced at $248.78 positioning it in the higher-end market. Furthermore, the stock has an average trading volume of 779,735.00 indicating moderate liquidity. With a mid-range market capitalization of $21,388,195,765.00 the company is a steady performer. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape. STERIS plc belongs to the Healthcare sector, driving innovation and growth within its operational domains. The company's commitment to quality and service ensures that it meets the evolving demands of the healthcare sector, thereby enhancing its competitive edge and market position.
Is STERIS plc (STE) a good investment?
Investing in STERIS plc (STE) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.
What is STERIS plc (STE)'s stock forecast?
Analysts predict STERIS plc stock to fluctuate between $204.90 (low) and $269.44 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is STERIS plc's market capitalization?
As of 2026-03-20, STERIS plc's market cap is $21,388,195,765, based on 98,147,007 outstanding shares.
How does STERIS plc compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., STERIS plc has a Lower Market-Cap, indicating a difference in performance.
Does STERIS plc pay dividends?
STERIS plc pays dividends. The current dividend yield is 1.00%, with a payout of $0.63 per share.
How can I buy STERIS plc (STE) stock?
To buy STERIS plc (STE) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for STE. Place an order (Market, Limit, etc.).
What is the best time to invest in STERIS plc?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has STERIS plc stock ever split?
STERIS plc's last stock split was 2:1 on 1998-08-25.
How did STERIS plc perform in the last earnings report?
Revenue: $5,459,515,000 | EPS: $6.24 | Growth: 62.92%.
Where can I find STERIS plc's investor relations reports?
Visit https://www.steris.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for STERIS plc?
You can explore historical data from here
What is the all-time high and low for STERIS plc stock?
All-time high: $269.44 (2026-01-16) | All-time low: $159.21 (2022-10-13).
What are the key trends affecting STERIS plc stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
STERIS offers a resilient, high-quality business model with some premium valuation, benefiting from hard-to-replicate sterilization networks and stable healthcare procedure volumes. Recent quarterly results included on-target 8% organic revenue growth but margin pressure from tariffs, with management raising tariff impact guidance by $10 million. STE stands to gain from stricter ethylene oxide (EtO) regulations, as compliance costs favor large, established players and will drive more outsourcing to its facilities.
seekingalpha.com
STERIS plc (STE) Q3 2026 Earnings Call Transcript
zacks.com
The headline numbers for Steris (STE) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zacks.com
Steris (STE) came out with quarterly earnings of $2.53 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $2.32 per share a year ago.
globenewswire.com
Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.96; adjusted EPS increased to $2.53 Fiscal 2026 outlook maintained DUBLIN, IRELAND, Feb. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 third quarter ended December 31, 2025. Total revenue from continuing operations for the third quarter of fiscal 2026 increased 9% to $1.5 billion compared with $1.4 billion in the third quarter of fiscal 2025.
globenewswire.com
DUBLIN, IRELAND, Jan. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on March 19, 2026, to shareholders of record at the close of business on February 17, 2026.
zacks.com
STE enters Q3 earnings with revenues seen up 8% to $1.48B and EPS rising 9.1% to $2.53, supported by strength in Healthcare, AST and Life Sciences.
globenewswire.com
DUBLIN, IRELAND, Jan. 21, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 third quarter results at 9:00 a.m. ET on February 5, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
zacks.com
Steris (STE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
defenseworld.net
Addenda Capital Inc. acquired a new stake in STERIS plc (NYSE: STE) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 18,834 shares of the medical equipment provider's stock, valued at approximately $4,660,000. Other large investors also recently modified their
See all news
